The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans
Open accessAbstract
Vitamin D regulates the renin-angiotensin system (RAS) in experimental animals, but corresponding human data are limited. We examined the relation between plasma 25-hydroxyvitamin D and elements of the RAS in 184 normotensive individuals in high sodium balance; these included circulating levels of plasma renin activity and angiotensin II (Ang II) and the renal plasma flow response to infused Ang II, which is an indirect measure of the intrinsic RAS activity in the kidney. Compared with individuals with sufficient 25-hydroxyvitamin D levels (≥30.0 ng/mL), those with insufficiency (15.0 to 29.9 ng/mL) and deficiency (<15.0 ng/mL) had higher circulating Ang II levels ( P for trend=0.03). Moreover, those with vitamin D deficiency had significantly blunted renal plasma flow responses to infused Ang II (mean decrease of 115 mL/min per 1.73 m 2 in renal plasma flow versus 145 mL/min per 1.73 m 2 among those with sufficient vitamin D levels; P for trend=0.009). Although plasma renin activity was higher among individuals with insufficient levels of vitamin D, the result was not statistically significant. These data suggest that low plasma 25-hydroxyvitamin D levels may result in upregulation of the RAS in otherwise healthy humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We previously showed that vitamin D deficiency blunts tissue-responsiveness to exogenous AngII by inducing a state of high tissue-RAAS activity4,6,31; this blunted sensitivity to AngII could be corrected by lowering the tissue-RAAS with an ACE inhibitor or vitamin D3 therapy4,33.”
From Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone (2014) · cites this paper as [31]
In the citing paper
“When integrated with the findings from Study 1 (Figure 1a–c), an incremental relationship between the RAAS and PTH was observed, which was modulated by AngII dose, as well as by ACE inhibition and vitamin D status (both of which sensitize the tissue responsiveness to AngII infusion)4,6,31–33.”
From Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone (2014) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Dobnig, H. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1340 · Cited by 1,209
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension
Forman, J. P., Giovannucci, E. L., Holmes, M. D., Bischoff-Ferrari, H. A., Tworoger, S. S., Willett, W. C., & Curhan, G. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087288 · Cited by 903
Self-citationImmunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
van Etten, E., & Mathieu, C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.002 · Cited by 882
Wood, R. J., Tchack, L., & Taparia, S. (2001) · BMC Physiology · doi:10.1186/1472-6793-1-11 · Cited by 847
Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Ajani, U. A., McGuire, L. C., & Liu, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1228 · Cited by 667
D’Ambrosio, D., Cippitelli, M., Cocciolo, M., Mazzeo, D., Lucia, P. D., Lang, R., Sinigaglia, F., & Panina‐Bordignon, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1050 · Cited by 649
Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance
Forouhi, N. G., Luan, J., Cooper, A., Boucher, B. J., & Wareham, N. J. (2008) · Diabetes · doi:10.2337/db08-0593 · Cited by 618
Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure
Li, Y. C., Qiao, G., Uskoković, M. R., Xiang, W., Zheng, W., & Kong, J. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.004 · Cited by 616
Vitamin D Receptor: New Assignments for an Already Busy Receptor
Norman, A. W. (2006) · Endocrinology · doi:10.1210/en.2006-0946 · Cited by 583
Scragg, R. K. R., Sowers, M., & BELL, C. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.01.017 · Cited by 579
Sugden, J., Davies, J. I., Witham, M. D., Morris, A. D., & Struthers, A. D. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02360.x · Cited by 549
Mineral Metabolism and Arterial Functions in End-Stage Renal Disease
London, G. M., Guérin, A. P., Verbeke, F., Pannier, B., Boutouyrie, P., Marchais, S. J., & Métivier, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060573 · Cited by 408
Zhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D., & Miao, D. (2008) · Kidney International · doi:10.1038/ki.2008.101 · Cited by 402
Alroy, I., Towers, T. L., & Freedman, L. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5789 · Cited by 397
25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age
Hyppönen, E., Boucher, B. J., Berry, D. J., & Power, C. (2007) · Diabetes · doi:10.2337/db07-1122 · Cited by 390
Decreased plasma adiponectin concentration in patients with essential hypertension
Adamczak, M. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03197-7 · Cited by 387
Calcium-Regulating Hormones in Essential Hypertension
Resnick, L. M., MÜLLER, F. B., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-5-649 · Cited by 371
Vitamin D status and health correlates among German adults
Hintzpeter, B., Mensink, G., Thierfelder, W., Müller, M., & Scheidt‐Nave, C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602825 · Cited by 358
Karlsson, C., Lindell, K., Ottosson, M., Sjöström, L., Carlsson, B., & Carlsson, L. M. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5276 · Cited by 351
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women
Forman, J. P., Curhan, G. C., & Taylor, E. N. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.117630 · Cited by 334
Self-citationHollenberg, N. K., CHENITZ, W. R., Adams, D. F., & Williams, G. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107748 · Cited by 333
Vitamin D, glucose tolerance and insulinaemia in elderly men
Baynes, K., Boucher, B. J., Feskens, E. J. M., & Kromhout, D. (1997) · Diabetologia · doi:10.1007/s001250050685 · Cited by 314
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. (2007) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus
Scragg, R. K. R., Holdaway, I. M., Singh, V. K., Metcalf, P., Baker, J., & Dryson, E. W. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01040-k · Cited by 290
Reis, J. P., von Mühlen, D. G., Kritz‐Silverstein, D. C., Wingard, D. L., & Barrett-Connor, E. L. (2007) · Diabetes Care · doi:10.2337/dc06-2438 · Cited by 281
Prevalence of Vitamin D Insufficiency in Obese Children and Adolescents
Smotkin-Tangorra, M., Purushothaman, R., Gupta, A., Nejati, G., Anhalt, H., & Ten, S. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.7.817 · Cited by 219
Judd, S. E., Nanes, M. S., Ziegler, T. R., Wilson, P. W. F., & Tangpricha, V. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.136 · Cited by 214
Karlsson, C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.3925 · Cited by 197
Mizobuchi, M., Morrissey, J. J., Finch, J. L., Martin, D. R., Liapis, H., Akizawa, T., & Slatopolsky, E. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091028 · Cited by 196
Gannagé‐Yared, M., Chédid, R., Khalifé, S., Azzi, E., Zoghbi, F., & Halaby, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0952 · Cited by 182
Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
Shoback, D. M., Williams, G. H., Moore, T. J., Dluhy, R. G., Podolsky, S., & Hollenberg, N. K. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111176 · Cited by 176
Mizwicki, M. T., & Norman, A. W. (2009) · Science Signaling · doi:10.1126/scisignal.275re4 · Cited by 170
Hopkins, P. N., Lifton, R. P., Hollenberg, N. K., Jeunemaı̂tre, X., Hallouin, M., Skuppin, J., Williams, C. S., Dluhy, R. G., Lalouel, J.-M., Williams, R. R., et al. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00008 · Cited by 156
Burgess, E. D., Hawkins, R. G., & Watanabe, M. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.12.903 · Cited by 132
Graciano, M. L., Cavaglieri, R. D. C., Dellê, H., Dominguez, W. V., Casarini, D. E., Malheiros, D. M. A. C., & Noronha, I. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131528.00773.a9 · Cited by 131
Wong, M. S. K., Delansorne, R., Man, R. Y. K., & Vanhoutte, P. M. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00116.2008 · Cited by 127
Li, J., & Brasier, A. R. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.3.8833654 · Cited by 104
Deb, D. K., Chen, Y., Zhang, Z., Zhang, Y., Szeto, F. L., Wong, K. E., Kong, J., & Li, Y. C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00002.2009 · Cited by 103
Renal vascular response to interruption of the renin-angiotensin system in normal man
Hollenberg, N. K., Williams, G. H., Taub, K. J., Ishikawa, I., Brown, C., & Adams, D. F. (1977) · Kidney International · doi:10.1038/ki.1977.113 · Cited by 80
Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells
Wakasugi, M., NOGUCHI, T., Inoue, M., Kazama, Y.-I., Tawata, M., KANEMARU, Y., & Onaya, T. (1991) · Prostaglandins · doi:10.1016/0090-6980(91)90072-n · Cited by 76
Hollenberg, N. K., Williams, G. H., Burger, B. M., CHENITZ, W. R., Hooshmand, I., & Adams, D. F. (1976) · Circulation Research · doi:10.1161/01.res.38.1.35 · Cited by 73
Goto, A., Ikeda, T., Tobian, L. J., Iwai, J., & Johnson, M. A. (1981) · Clinical Science · doi:10.1042/cs061053s · Cited by 70
Behavioural and physical characteristics associated with vitamin D status in women
Pasco, J. A., Henry, M. J., Nicholson, G. C., Brennan-Olsen, S. L., & Kotowicz, M. A. (2009) · Bone · doi:10.1016/j.bone.2009.02.020 · Cited by 68
Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake
Raji, A., Williams, G. H., Jeunemaı̂tre, X., Hopkins, P. N., Hunt, S. C., Hollenberg, N. K., & Seely, E. W. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00013 · Cited by 63
Landin‐Wilhelmsen, K., Wilhelmsen, L., Wilske, J., Lappas, G., Rosén, T., Lindstedt, G., Lundberg, P. A., & Bengtsson, B. ‐. (1995) · PubMed · Cited by 62
Wark, J. D., Larkins, R. G., Eisman, J. A., & Wilson, K. R. (1981) · Clinical Science · doi:10.1042/cs0610053 · Cited by 38
Duprez, D., Buyzere, M. D., Backer, T. L. M. D., & Clement, D. L. (1994) · Blood Pressure · doi:10.3109/08037059409102292 · Cited by 33
Renal response to captopril reflects state of local renin system in healthy humans
Fisher, N. D. L., Price, D. A., Litchfield, W. R., Williams, G. H., & Hollenberg, N. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00579.x · Cited by 27
Self-citationKülah, E., Dursun, A., Aktunç, E., Açıkgöz, Ş., Aydın, M., Can, M., & Dursun, A. (2007) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e32813fa371 · Cited by 18
Kähönen, M. A. P., ppi, S. N., Jolma, P., nen, N. H.-K. A. H. O., Tolvanen, J., Saha, H. H. T., Koivisto, P. A., Krogerus, L. A., Kalliovalkama, J., & rsti, I. P. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200309000-00002 · Cited by 17
Immunological effects of 1alpha-hydroxycholecalciferol (1alpha-OH-D3) and its metabolites.
Miyakoshi, H., Aoki, T., & Hirasawa, Y. (1981) · PubMed · Cited by 12
Cited by
Sorted by citations
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2015) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 2,097
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez‐Arias, L., Alonso‐Montes, C., Cannata, P., Martín-Carro, B., Martín, J. L. F., Naves‐Díaz, M., Carrillo‐López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 402
George, P., Pearson, E. R., & Witham, M. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03672.x · Cited by 357
Seasonal variations in cardiovascular disease
Stewart, S., Keates, A. K., Redfern, A., & McMurray, J. J. V. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.76 · Cited by 338
Effect of Vitamin D Supplementation on Blood Pressure
Beveridge, L. A., Struthers, A. D., Khan, F., Jorde, R., Scragg, R. K. R., Macdonald, H. M., Alvarez, J. A., Boxer, R. S., Dalbeni, A., Gepner, A. D., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0237 · Cited by 315
Metadata
- Authors
- Forman, J. P., Williams, J. S., & Fisher, N. D. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Hypertension
- Published
- 2010-05
- Volume
- 55
- Issue
- 5
- Pages
- 1283-1288
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- PMC
- PMC3023301
- OpenAlex
- W2133707802
- Cited by
- 331
- References
- 54
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 12 · 2023: 21 · 2022: 24 · 2021: 27 · 2020: 24 · 2019: 14 · 2018: 22 · 2017: 23 · 2016: 19 · 2015: 31 · 2014: 25 · 2013: 25 · 2012: 26
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL084236, HL-079929, K08HL079929, HL084236)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- 25-hydroxyvitamin D, vitamin D deficiency, renin-angiotensin system, angiotensin II, plasma renin activity, renal plasma flow, normotensive subjects
- MeSH terms
- Adult, Angiotensin II, Female, Homeostasis, Humans, Infusions, Intravenous, Male, Middle Aged, p-Aminohippuric Acid, Reference Values, Renal Circulation, Renin-Angiotensin System, Sodium, Sodium, Dietary, Vitamin D, Patient Selection, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
